Patient Access Network Foundation uses the following criteria to
determine eligibility for assistance:
1. You have to be insured and your insurance has to cover the
medication for which you are seeking assistance.
2. The medication you take must fight the disease directly.
3. You have to be a US resident.
4. Your income must fall below 300% of the Federal Poverty
Level.
Click
here
for the Federal Poverty Guidelines
Non-Hodgkin's lymphoma (NHL) is a malignant growth of B or T cells in the lymph system. In the US, childhood Non-Hodgkin's lymphomas make up about 5 percent of the cases of NHL diagnosed each year. Unlike the approximate 29 adult non-Hodgkin's lymphomas, childhood NHLs fall into four broad categories: lymphoblastic lymphoma (30 percent), Burkitt's lymphoma (40 percent), Anaplastic Large Cell Lymphoma (10 percent), and large B-cell lymphoma (20 percent).
There are several treatments for NHL. Usually chemotherapy is used. If the lymphoma is localized, radiation therapy might be used possibly in conjunction with chemotherapy. In some types of advanced NHL (but not all) bone marrow or peripheral blood stem cell transplants can be used (often for serious/unresponsive cases).
Private insurance and Medicare are the most common types of health coverage for patients with NHL. Both can lead to access issues for many patients. As a result, low-to-moderate income beneficiaries are often unable to afford the out-of-pocket costs associated with their treatment.
